Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-6 | 25569.0 | 72 | |
RA1869 | TNF-a | 100 | ng/mL | 1 | IL-6 | 24838.0 | 61 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-6 | 11448.5 | 66 | |
N2759 | TNF-a | 100 | ng/mL | 1 | IL-6 | 13336.0 | 52 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-6 | 23535.5 | 40 | |
RA1931 | TNF-a | 100 | ng/mL | 1 | IL-6 | 15544.0 | 52 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-6 | 20291.0 | 71 | |
N2586 | TNF-a | 100 | ng/mL | 1 | IL-6 | 22096.0 | 63 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 1590.0 | 77 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 6629.0 | 66 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 592.0 | 62 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 13665.5 | 74 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 3733.0 | 69 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 10678.0 | 72 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 3407.0 | 51 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 16147.0 | 41 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 35863.5 | 70 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 37817.0 | 61 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 37759.5 | 56 | |
N2759 | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 39896.0 | 47 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 36686.0 | 56 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 39325.0 | 58 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 41290.0 | 58 | |
N2586 | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 40810.0 | 55 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-6 | 1337.0 | 69 |